This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Curtin University of Technology, King's College London. Active years: 2006-2012.
Company Filing History:
Years Active: 2006-2012
Title: Barbara Mulloy: Innovator in Therapeutic Agents
Introduction
Barbara Mulloy is a distinguished inventor based in London, GB. She has made significant contributions to the field of therapeutic agents, particularly in the development of chemical agents for the treatment of chronic diseases. With a total of 2 patents, her work has the potential to impact various medical conditions.
Latest Patents
Mulloy's latest patents include "Therapeutic heparins and their binding to interleukins 4 and 5" and "Product from starfish." The first patent relates to chemical agents useful in the prophylaxis and treatment of chronic disease conditions, including inflammatory diseases, metastatic cancers, and infections by pathogenic agents. The invention focuses on glycosaminoglycan (GAG) molecules and their therapeutic applications. The second patent describes a product derived from starfish, which possesses properties such as anti-fouling, anti-adhesive, and anti-inflammatory effects.
Career Highlights
Throughout her career, Barbara Mulloy has worked with notable institutions, including Curtin University of Technology and King's College London. Her research has contributed to advancements in therapeutic agents and their applications in medicine.
Collaborations
Mulloy has collaborated with esteemed colleagues, including Warren Charles Kett and Rebecca Lever. These partnerships have furthered her research and innovation in the field.
Conclusion
Barbara Mulloy is a prominent inventor whose work in therapeutic agents showcases her dedication to improving health outcomes. Her innovative patents reflect her commitment to addressing chronic diseases and advancing medical science.